BC
Birchview Capital Portfolio holdings
AUM
$101M
This Quarter Return
+0.66%
1 Year Return
+34.62%
3 Year Return
+103.2%
5 Year Return
+107.72%
10 Year Return
+352.1%
AUM
$167M
AUM Growth
+$167M
(-0.75%)
Cap. Flow
+$4.56M
Cap. Flow
% of AUM
2.73%
Top 10 Holdings %
Top 10 Hldgs %
72.22%
Holding
63
New
9
Increased
5
Reduced
4
Closed
1
Top Buys
| 1 |
Prothena Corp
PRTA
|
$1.56M |
| 2 |
TPTX
Turning Point Therapeutics, Inc. Common Stock
TPTX
|
$624K |
| 3 |
Acadia Pharmaceuticals
ACAD
|
$546K |
| 4 |
Zentalis Pharmaceuticals
ZNTL
|
$426K |
| 5 |
Akebia Therapeutics
AKBA
|
$379K |
Top Sells
| 1 |
Cullinan Oncology
CGEM
|
$386K |
| 2 |
Nektar Therapeutics
NKTR
|
$343K |
| 3 |
YTEN
Yield10 Bioscience, Inc. Common Stock
YTEN
|
$238K |
| 4 |
BLUE
bluebird bio
BLUE
|
$48K |
| 5 |
Ovintiv
OVV
|
$4.72K |
Sector Composition
| 1 | Healthcare | 96.67% |
| 2 | Energy | 1.69% |
| 3 | Consumer Staples | 0.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Bristol-Myers Squibb
BMY
$96B
| $53.2M | 31.82% | 796,106 +1,920 | +0.2% | +$128K |
|
|
AXDX
2
DELISTED
Accelerate Diagnostics
AXDX
| $18M | 10.74% | 2,232,857 +19,531 | +0.9% | +$157K |
|
3
Biodesix
BDSX
$62.6M
| $14.6M | 8.73% | 1,104,953 | – | – |
|
4
Neurocrine Biosciences
NBIX
$13.8B
| $7.81M | 4.67% | 80,200 | – | – |
|
5
QuidelOrtho
QDEL
$1.95B
| $7.65M | 4.57% | 59,684 +1,040 | +2% | +$133K |
|
|
6
Acadia Pharmaceuticals
ACAD
$4.38B
| $4.86M | 2.91% | 199,400 +22,400 | +13% | +$546K |
|
7
Biogen
BIIB
$19.4B
| $4.19M | 2.51% | 12,100 | – | – |
|
|
ALBO
8
DELISTED
Albireo Pharma, Inc. Common Stock
ALBO
| $3.91M | 2.34% | 111,000 | – | – |
|
9
Foghorn Therapeutics
FHTX
$286M
| $3.35M | 2.01% | 314,143 | – | – |
|
10
United Therapeutics
UTHR
$13.8B
| $3.23M | 1.93% | 18,000 | – | – |
|
11
Karyopharm Therapeutics
KPTI
$61.7M
| $2.37M | 1.42% | 230,000 | – | – |
|
|
BLUE
12
DELISTED
bluebird bio
BLUE
| $2.37M | 1.42% | 74,000 -1,500 | -2% | -$48K |
|
|
XLRN
13
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.34M | 1.4% | 18,672 | – | – |
|
14
Masimo
MASI
$7.59B
| $1.94M | 1.16% | 8,000 | – | – |
|
15
Elicio Therapeutics
ELTX
$172M
| $1.94M | 1.16% | 60,615 | – | – |
|
16
Vanda Pharmaceuticals
VNDA
$279M
| $1.72M | 1.03% | 80,000 | – | – |
|
17
Harrow
HROW
$1.44B
| $1.67M | 1% | 180,000 | – | – |
|
|
18
Prothena Corp
PRTA
$441M
| $1.56M | 0.93% | +30,247 | New | +$1.56M |
|
|
ARNA
19
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.5M | 0.9% | 22,000 | – | – |
|
|
CLR
20
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $1.47M | 0.88% | 38,600 | – | – |
|
|
AMRN
21
Amarin Corp
AMRN
$311M
| $1.31M | 0.79% | 300,000 | – | – |
|
|
IMGN
22
DELISTED
Immunogen Inc
IMGN
| $1.25M | 0.75% | 190,000 | – | – |
|
|
23
Nektar Therapeutics
NKTR
$568M
| $1.24M | 0.74% | 72,000 -20,000 | -22% | -$343K |
|
24
Alkermes
ALKS
$4.78B
| $1.23M | 0.73% | 50,000 +15,000 | +43% | +$368K |
|
|
25
Cullinan Oncology
CGEM
$445M
| $1.16M | 0.7% | 45,114 -15,000 | -25% | -$386K |
|